Bachir Latli

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 12

Top Venues

Journal of labelled compounds & radiopharmaceuticals

Boehringer Ingelheim Corp USA

Stony Brook University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Boehringer Ingelheim Corp USA Aug 31 1998

United States

Sr. Research Fellow :: Chemical Development

University of California Berkeley - Jul 01 1998

United States

Specialist :: Environmental Chemistry and Toxicology

Education History

Stony Brook University Aug 20 1988 - Jul 24 1991

United States

PHD :: Chemistry Department

Stony Brook University Aug 20 1986 - Aug 20 1988

United States

MSC :: Chemistry Department

Publications

Bachir Latli, Matt J Hrapchak, Maxim Chevliakov, Chutian Shu
Carbon 14 and Carbon 13 Syntheses of Velagliflozin. Journal of labelled compounds & radiopharmaceuticals (2024)
Bachir Latli, Matt J Hrapchak, Maxim Chevliakov, Chutian Shu
Carbon 14 and Carbon 13 Syntheses of Velagliflozin. Journal of labelled compounds & radiopharmaceuticals 67 (5) (2024)
Bachir Latli, Matt J Hrapchak, Thomas G Tampone, Rogelio P Frutos, Heewon Lee
Carbon 14 and stable isotope synthesis of two potent and selective phosphodiesterase type 4 inhibitors. Journal of labelled compounds & radiopharmaceuticals (2023)
Bachir Latli, Matt J Hrapchak, Jonathan T Reeves, Heewon Lee, Jinhua J Song
Synthesis of beta-site amyloid precursor protein-cleaving enzyme 1 inhibitors BI 1147560 and BI 1181181 labeled with carbon-14 and deuterium. Journal of labelled compounds & radiopharmaceuticals (2023)
Bachir Latli, Matt J Hrapchak, Maxim Chevliakov, Lalith P Samankumara, Rogelio P Frutos, Heewon Lee
Stable isotope synthesis of glycine transporter 1 inhibitor Iclepertin (BI 425809) and its major metabolites. Journal of labelled compounds & radiopharmaceuticals (2023)
Bachir Latli, Matt J Hrapchak, Lalith P Samankumara, Daniel R Fandrick, Scott Pennino, Heewon Lee, Jinhua J Song
Synthesis of BI 894416 and BI 1342561, Two Potent and Selective Spleen Tyrosine Kinase Inhibitors, Labelled with Carbon 14 and with Deuterium. Journal of labelled compounds & radiopharmaceuticals (2023)
Bachir Latli, Matt J Hrapchak, Jonathan T Reeves, Heewon Lee, Jinhua J Song
Synthesis of Beta-Site Amyloid Precursor Protein-Cleaving Enzyme 1 Inhibitors BI 1147560 and BI 1181181 Labeled with Carbon-14 and Deuterium. Journal of labelled compounds & radiopharmaceuticals (2023)
Bachir Latli, Matt J Hrapchak, Rogelio P Frutos, Heewon Lee, Jinhua J Song
Carbon 14 synthesis of glycine transporter 1 inhibitor Iclepertin (BI 425809) and its major metabolites. Journal of labelled compounds & radiopharmaceuticals (2023)
Bachir Latli, Amy Gao, Valerie Kvaternick, Berhane Tecle, Scott Pennino, Nathan K Yee, Jeff Song
Synthesis of stable isotope-labelled firocoxib. Journal of labelled compounds & radiopharmaceuticals 63 (8) (2020)
Bachir Latli, Matt Hrapchak, Guisheng Li, Jon Lorenz, Josh Horan, Carl A Busacca, Chris H Senanayake
Synthesis of highly potent lymphocyte function-associated antigen-1 antagonists labeled with carbon-14 and with stable isotopes, part 3. Journal of labelled compounds & radiopharmaceuticals 62 (2) (2018)
Bachir Latli, Matt Hrapchak, Maxim Cheveliakov, Jonathan T Reeves, Maurice Marsini, Carl A Busacca, Chris H Senanayake
Potent and selective CC chemokine receptor 1 antagonists labeled with carbon-13, carbon-14, and tritium. Journal of labelled compounds & radiopharmaceuticals (2018)
Bachir Latli, Matt Hrapchak, Jolaine Savoie, Yongda Zhang, Carl A Busacca, Chris H Senanayake
Potent and selective inhibitors of 11β-hydroxysteroid dehydrogenase type 1 labeled with carbon-13 and carbon-14. Journal of labelled compounds & radiopharmaceuticals 60 (9) (2017)

Bachir Latli.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Bachir Latli